Similar articles for PMID: 18335204

Year	Number of Results
2003	2
2004	4
2005	10
2006	14
2007	20
2008	11
2009	12
2010	10
2011	9
2012	11
2013	4
2014	3
2015	2
2016	4
2017	3
2018	3
2019	1
2020	4
2021	2
2022	2
2023	1
2024	0

1

A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications.

Tammaro P, Flanagan SE, Zadek B, Srinivasan S, Woodhead H, Hameed S, Klimes I, Hattersley AT, Ellard S, Ashcroft FM. Tammaro P, et al. Diabetologia. 2008 May;51(5):802-10. doi: 10.1007/s00125-008-0923-1. Epub 2008 Mar 12. Diabetologia. 2008. PMID: 18335204 Free PMC article.

2

Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.

Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM. Proks P, et al. Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17539-44. doi: 10.1073/pnas.0404756101. Epub 2004 Dec 6. Proc Natl Acad Sci U S A. 2004. PMID: 15583126 Free PMC article.

3

Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.

Proks P, Girard C, Baevre H, Njølstad PR, Ashcroft FM. Proks P, et al. Diabetes. 2006 Jun;55(6):1731-7. doi: 10.2337/db05-1420. Diabetes. 2006. PMID: 16731836

4

Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.

Shimomura K, Girard CA, Proks P, Nazim J, Lippiat JD, Cerutti F, Lorini R, Ellard S, Hattersley AT, Barbetti F, Ashcroft FM. Shimomura K, et al. Diabetes. 2006 Jun;55(6):1705-12. doi: 10.2337/db05-1640. Diabetes. 2006. PMID: 16731833

5

Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy.

Lin CW, Lin YW, Yan FF, Casey J, Kochhar M, Pratt EB, Shyng SL. Lin CW, et al. Diabetes. 2006 Jun;55(6):1738-46. doi: 10.2337/db05-1571. Diabetes. 2006. PMID: 16731837

6

Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk.

Vedovato N, Cliff E, Proks P, Poovazhagi V, Flanagan SE, Ellard S, Hattersley AT, Ashcroft FM. Vedovato N, et al. Diabetologia. 2016 Jul;59(7):1430-1436. doi: 10.1007/s00125-016-3964-x. Epub 2016 Apr 27. Diabetologia. 2016. PMID: 27118464 Free PMC article.

7

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.

Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, Flanagan SE, Babiker T, Thomas NJ, Shepherd MH, Ellard S, Klimes I, Szopa M, Polak M, Iafusco D, Hattersley AT, Njølstad PR; Neonatal Diabetes International Collaborative Group. Bowman P, et al. Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646. doi: 10.1016/S2213-8587(18)30106-2. Epub 2018 Jun 4. Lancet Diabetes Endocrinol. 2018. PMID: 29880308 Free PMC article.

8

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.

Babiker T, Vedovato N, Patel K, Thomas N, Finn R, Männikkö R, Chakera AJ, Flanagan SE, Shepherd MH, Ellard S, Ashcroft FM, Hattersley AT. Babiker T, et al. Diabetologia. 2016 Jun;59(6):1162-6. doi: 10.1007/s00125-016-3921-8. Epub 2016 Mar 31. Diabetologia. 2016. PMID: 27033559 Free PMC article.

9

Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.

Girard CA, Shimomura K, Proks P, Absalom N, Castano L, Perez de Nanclares G, Ashcroft FM. Girard CA, et al. Pflugers Arch. 2006 Dec;453(3):323-32. doi: 10.1007/s00424-006-0112-3. Epub 2006 Sep 22. Pflugers Arch. 2006. PMID: 17021801

10

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.

Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT; Neonatal Diabetes International Collaborative Group. Pearson ER, et al. N Engl J Med. 2006 Aug 3;355(5):467-77. doi: 10.1056/NEJMoa061759. N Engl J Med. 2006. PMID: 16885550 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

117 results

Results by year